Riskpilot← Back to searchSign inGet full accessNORTANN AS
ASActiveOrg 971004991Skippergata 33, 0154 OsloManufacture of medical and dental instruments and supplies · NACE 3250Est. 19943 employeeswww.nortann.no
Revenue 2023
NOK 3,5M
-2% vs 2022
EBITDA margin
3.8%
+168% vs 2022
Equity ratio
35.5%
Financial strength
Net profit 2023
NOK -43K
+90% vs 2022
| Revenue | NOK 3,5M | -2% |
| EBITDA | NOK 134K | +168% |
| Net profit | NOK -43K | +90% |
| Total assets | NOK 1,1M | -16% |
| Equity | NOK 388K | +281% |
| Employees | 3 | — |
Legal name
NORTANN AS
Org number
971004991
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
10. juni 1994
Share capital
—
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Levere alle typer tannerstatninger.
Address
Skippergata 33, 0154 Oslo
Phone
+4722292714
Email
post@nortann.no
Website
www.nortann.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 459 | 4 474 | 3 863 | 4 578 | 4 972 | 4 021 | 3 415 | 3 686 | 2 646 | 2 445 | 3 118 | 2 599 | 4 183 | 4 638 | 3 578 | 3 502 |
| Staff expenses | −0 | −1 561 | −1 378 | −1 450 | −1 706 | −2 222 | −2 282 | −1 767 | −1 383 | −1 118 | −1 216 | −1 315 | −1 423 | −1 730 | −1 993 | −1 988 | −1 833 |
| EBITDA | 0 | 124 | 355 | 188 | 296 | 382 | 96 | 27 | 218 | 282 | 208 | 468 | 31 | 920 | 634 | −196 | 134 |
| Depreciation & amort. | −0 | −42 | −29 | −53 | −153 | −164 | −98 | −20 | −108 | −173 | −190 | −185 | −247 | −248 | −207 | −225 | −177 |
| EBIT | 0 | 82 | 326 | 135 | 143 | 218 | −2 | 7 | 110 | 109 | 18 | 283 | −216 | 672 | 427 | −421 | −44 |
| Net financials | 0 | 3 | −7 | 8 | −19 | 21 | 9 | −8 | −1 | 9 | −5 | −4 | −2 | −6 | −4 | −3 | 1 |
| Profit before tax | 0 | 86 | 319 | 142 | 124 | 239 | 7 | −1 | 109 | 118 | 13 | 279 | −218 | 667 | 424 | −424 | −43 |
| Tax | −0 | −0 | 77 | 26 | 54 | 86 | 12 | −0 | −0 | −0 | 7 | 62 | −0 | 143 | 102 | −0 | −0 |
| Net profit | 0 | 86 | 242 | 116 | 70 | 154 | −4 | −1 | 109 | 118 | 6 | 217 | −218 | 523 | 322 | −424 | −43 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 655 | 965 | 1 183 | 1 212 | 1 099 | 960 | 1 824 | 1 559 | 2 010 | 1 767 | 2 001 | 1 550 | 1 825 | 1 812 | 1 297 | 1 095 |
| Equity | — | 90 | 133 | 182 | 132 | 124 | 120 | 119 | 426 | 544 | 550 | 767 | 549 | 565 | 526 | 102 | 388 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 565 | 832 | 1 001 | 1 080 | 975 | 840 | 1 705 | 1 133 | 1 466 | 1 218 | 1 234 | 1 001 | 1 260 | 1 286 | 1 195 | 706 |
| Total debt | 0 | 565 | 832 | 1 001 | 1 080 | 975 | 840 | 1 705 | 1 133 | 1 466 | 1 218 | 1 234 | 1 001 | 1 260 | 1 286 | 1 195 | 706 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20072023
Equity ratio
35.5%
This company
38.2%
Market median
+7% vs market
20072023
Return on equity
-11.0%
This company
18.4%
Market median
-160% vs market
20072023
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20072023
Asset turnover
3.20×
This company
1.12×
Market median
+186% vs market
20072023
Debt / equity
1.82×
This company
0.62×
Market median
-194% vs market
20072023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DK Chief Executive Officer | Chief Executive Officer | 1994 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 1994 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Citadella As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Citadella As
NORTANN AS Board members of NORTANN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Kjølstad | Chief Executive Officer | 0 companies |
| Eldbjørg Løken Kjølstad | Chairman | 0 companies |
| Kim Robøle | Chairman | 0 companies |
| Anders Abrahamsen | Board of Directors | 0 companies |